Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

The Children's Research Institute

Cancer Biology and Experimental Cancer Therapy

Our Cancer Biology and Experimental Cancer Therapy research includes a focus on brain tumor biomarkers, led by Brian Rood, M.D. Our Neurofibromatosis Research Group continues its work on the utility of MEK inhibitors (MEKi) in preventing the development of a variety of neurofibromatosis type 1 (NF1)-associated diseases. The D. Ashley Hill Laboratory focuses its research on the rare lung cancer known as pleuropulmonary blastoma (PPB).

  • Brain Tumor Biomarkers
  • Neurofibromatosis Program
  • Pleuropulmonary Blastoma (PPB)